Sale!

DTNA Gene Left Ventricular Noncompaction 1 with or without Congenital Heart Defects NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The DTNA Gene Left Ventricular Noncompaction 1 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the DTNA gene associated with left ventricular noncompaction cardiomyopathy. This specialized genetic test utilizes next-generation sequencing technology to detect pathogenic variants that can cause abnormal heart muscle development, leading to potentially serious cardiac complications. The test is particularly valuable for individuals with family history of cardiomyopathy, unexplained heart failure symptoms, or congenital heart defects. By providing precise genetic information, this $500 USD test enables early intervention, personalized treatment strategies, and informed family planning decisions. Our advanced NGS methodology ensures high accuracy in detecting DTNA gene mutations that contribute to LVNC1, helping cardiologists develop targeted management plans for affected patients and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

DTNA Gene Left Ventricular Noncompaction 1 with or without Congenital Heart Defects NGS Genetic DNA Test

Comprehensive Genetic Testing for Cardiac Health

The DTNA Gene Left Ventricular Noncompaction 1 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics, offering precise detection of mutations associated with this rare but serious cardiac condition. Left ventricular noncompaction (LVNC) is a genetic cardiomyopathy characterized by abnormal trabeculations in the left ventricle, creating a “spongy” appearance that can lead to heart failure, arrhythmias, and thromboembolic events.

What This Advanced Genetic Test Detects

This specialized NGS-based test specifically targets the DTNA (dystrobrevin alpha) gene, which plays a crucial role in cardiac muscle development and function. The test identifies:

  • Pathogenic variants in the DTNA gene associated with LVNC1
  • Missense, nonsense, and frameshift mutations
  • Copy number variations affecting DTNA gene function
  • Genetic markers linked to congenital heart defects
  • Inheritance patterns for family risk assessment

Who Should Consider DTNA Genetic Testing?

Clinical Indications and Symptoms

This test is recommended for individuals experiencing:

  • Unexplained heart failure symptoms at a young age
  • Family history of cardiomyopathy or sudden cardiac death
  • Abnormal echocardiogram findings showing trabeculations
  • Congenital heart defects with suspected genetic component
  • Arrhythmias or palpitations of unknown origin
  • Exercise intolerance or fatigue with cardiac involvement
  • Children with developmental cardiac abnormalities

Significant Benefits of DTNA Genetic Testing

Transformative Clinical Advantages

Undergoing DTNA gene testing provides numerous critical benefits:

  • Early Diagnosis: Enables detection before severe symptoms develop
  • Personalized Treatment: Guides targeted therapeutic interventions
  • Family Screening: Identifies at-risk relatives for preventive care
  • Reproductive Planning: Informs family planning decisions
  • Prognostic Information: Helps predict disease progression
  • Reduced Diagnostic Uncertainty: Provides definitive answers

Understanding Your Test Results

Comprehensive Result Interpretation

Your DTNA gene test results will fall into one of several categories:

  • Positive Result: Indicates a pathogenic mutation in the DTNA gene, confirming genetic predisposition to LVNC1. Requires cardiology follow-up and family screening.
  • Negative Result: No pathogenic DTNA mutations detected, though other genetic causes may still be present.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unknown clinical impact, requiring ongoing monitoring.
  • Carrier Status: Important for family planning and genetic counseling.

Test Details and Pricing

Test Component Details
Test Name DTNA Gene Left Ventricular Noncompaction 1 with or without Congenital Heart Defects NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Cardiology and Genetics

Pre-Test Requirements and Preparation

Essential Pre-Testing Steps

Before undergoing DTNA genetic testing, patients should complete:

  • Comprehensive clinical history documentation
  • Genetic counseling session with certified genetic counselor
  • Detailed pedigree chart creation of affected family members
  • Cardiac evaluation and echocardiogram review
  • Informed consent process for genetic testing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing nationwide.

Take Control of Your Cardiac Health Today

Don’t wait to get answers about your genetic cardiac risk. Early detection of DTNA gene mutations can significantly impact treatment outcomes and family health planning. Our expert genetic counselors and cardiology specialists are ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your DTNA genetic test consultation and take the first step toward comprehensive cardiac genetic assessment.

Book your appointment now and benefit from our current promotional pricing of $500 USD for this advanced NGS genetic analysis. Our team is available to answer your questions and help you understand how DTNA testing can provide valuable insights into your cardiovascular health and genetic risk factors.